2025-03-06

CPHI 2024, held in Greater Noida, served as a premier platform for pharmaceutical and biotechnology companies to showcase their latest advancements. Industry leaders from across the globe gathered to discuss innovative solutions, emerging technologies, and the future of pharma manufacturing. The event provided a valuable opportunity for companies to strengthen industry connections, introduce breakthrough technologies, and explore new business collaborations.

Among the key participants was Freudenberg, a global leader in advanced materials and technology solutions, catering to the pharmaceutical, biopharmaceutical, and medical device industries. With a strong presence in India and worldwide, Freudenberg continues to push boundaries in sealing, filtration, and single-use technologies. At this year’s CPHI, the company unveiled several new products, reinforcing its commitment to enhancing safety, efficiency, and compliance in pharmaceutical production.

Freudenberg’s Innovations at CPHI 2024

Freudenberg's team, comprising experts from different divisions, presented their latest innovations tailored for the pharmaceutical industry. Their exhibits included single-use assemblies, light-sensitive tubing, filtration systems, and high-performance sealing solutions—each designed to address critical industry challenges and meet evolving regulatory requirements.

Here’s what Freudenberg’s key representatives had to say about their participation at CPHI 2024:

Rüdiger (Rudi) Gall – General Manager / VP of Business Development SC EMEA & Global Pharma, Germany, Freudenberg Medical Europe

"This year, we introduced two major innovations: our single-use assembly system and Pharma-Flow Gas Premium UV Shield Tubing. These solutions enhance safety, efficiency, and contamination control in pharmaceutical production. Our single-use assemblies include advanced over-molding techniques for seamless tubing connections, while our UV-shielded tubing protects light-sensitive drugs—features that set us apart from conventional market offerings. The response at CPHI has been very positive, further validating India as a key growth market for us."

Falgun Jani – Business Head, India, Freudenberg Medical

"We are launching ASTC UV tubing, a first-of-its-kind black-colored tubing designed to handle photosensitive liquids. The specialized medical-grade pigment provides UV protection, making it a game-changer for drug stability. Another highlight is our single-use assembly system, which eliminates leakage risks by utilizing molded connections instead of traditional physical attachments. The expo has been a fantastic platform to engage with our existing customers and introduce these cutting-edge solutions to the industry."

Chinmay Korad – Country Head, Pharma, Freudenberg Filtration Technologies India

"Pharmaceutical companies increasingly require dedicated clean zones, and our Fan Filter Units (FFUs) cater to this growing need. Our FFUs come with dual-fan technology, ensuring extended lifecycle and high-efficiency filtration. Additionally, we have implemented AI-driven automation tools to optimize manufacturing, track production status, and enhance quality control. This commitment to digitalization is helping us drive greater efficiency and reliability in pharma manufacturing."

Senthil Kumar E – Sr. General Manager, Industrial Services Division, Freudenberg-NOK India

"We showcased our Radiamatic® HTS II, a high-performance radial shaft seal designed for hygienic sealing in process industries. This PTFE-based seal offers superior media resistance and low friction, making it ideal for pharmaceutical applications. Alongside this, our profile and inflatable seals provide enhanced durability, chemical resistance, and compliance with global regulatory standards. The strong interest at CPHI confirms the growing demand for high-quality sealing solutions in India."

Freudenberg’s Commitment to India and the Asia-Pacific Market

Freudenberg’s leadership emphasized India’s strategic importance in their global expansion plans. With the country’s pharmaceutical market growing at a CAGR of 12 percent, the company is committed to strengthening its local presence. Plans include expanding manufacturing facilities, increasing supply chain efficiency, and investing in R&D to support emerging pharmaceutical needs.

Beyond India, Freudenberg is also focusing on the Middle East and Bangladesh, ensuring that these markets benefit from their cutting-edge filtration, sealing, and fluid management solutions.

CPHI 2024 provided an excellent stage for Freudenberg to demonstrate its expertise in pharma manufacturing solutions. From single-use systems to AI-powered automation, from filtration technologies to high-performance sealing solutions, the company continues to innovate and lead in pharmaceutical process optimization.

As the industry moves toward greater efficiency, digitalization, and regulatory compliance, Freudenberg’s latest advancements reaffirm its position as a trusted partner for pharmaceutical manufacturers worldwide.